Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:23:17.000Z thumbnail image
  2. Check
    2 days ago
    Change Detected
    Summary
    The value of Last Update Posted (Estimated) has been updated to Last Update Posted. This change indicates that the last update for the study record was posted on a specific date without an estimated timeframe.
    Difference
    0.0%
    Check dated 2024-06-12T21:23:12.000Z thumbnail image
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 'Recruiting 2022-08-02' has recently changed to 'Active, not recruiting'. This change indicates that the status of the study has been updated to reflect that it is currently active but not actively recruiting participants.
    Difference
    6%
    Check dated 2024-06-11T20:46:55.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the dosing regimen for the Phase 1 trial studying the safety and efficacy of STRO-002 in combination with Bevacizumab for patients with advanced ovarian cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:30:44.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying requirements such as age, health condition, and prior treatments. This change provides more comprehensive information for researchers looking to enroll suitable candidates in the clinical trial.
    Difference
    41%
    Check dated 2024-05-22T20:30:24.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:36:23.000Z thumbnail image

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.